Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

December 2, 2020

Dr. Reddy’s and RDIF commence clinical trials for Sputnik V vaccine in India

Dr. Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) announced that they have commenced adaptive phase 2/3 clinical trials for Sputnik V vaccine in India after receiving the necessary clearance from the Central Drugs Laboratory, Kasauli, India.

Dr. Reddy’s and RDIF commence clinical trials for Sputnik V vaccine in India